
Magellan Health, Inc. (MGLN) Stock Overview
Explore Magellan Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Magellan Health, Inc. (MGLN)
Key Financials
Key Financials
Market Cap
0
P/E Ratio
605.27
EPS (TTM)
$11.19
ROE
0.00%
MGLN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Magellan Health, Inc. (MGLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 605.27 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.